Search



Search only items with full text availability
Current filters:

Clear current filters  or Add more filters

View Option



Results 11-20 of 35 (Search time: 0.001 seconds).

  Alterations in the High Density Lipoprotein Phenotype and HDL-Associated Enzymes in Subjects with Metabolic Syndrome (Journal article)

  The effects of rosuvastatin alone or in combination with fenofibrate or omega 3 fatty acids on inflammation and oxidative stress in patients with mixed dyslipidemia (Journal article)

  The effect of orlistat and ezetimibe, alone or in combination, on serum LDL and small dense LDL cholesterol levels in overweight and obese patients with hypercholesterolaemia (Journal article)

  Effect of rosuvastatin treatment on plasma visfatin levels in patients with primary hyperlipidemia (Journal article)

  Effects of combination of orlistat and micronised fenofibrate on lipid profile in overweight and obese patients with metabolic syndrome (Journal article)

  The effects of orlistat and fenofibrate, alone or in combination, on high-density lipoprotein subfractions and pre-beta1-HDL levels in obese patients with metabolic syndrome (Journal article)

  Dose-dependent Effect of Rosuvastatin Treatment on HDL-subfraction Phenotype in Patients With Primary Hyperlipidemia (Journal article)

  The effects of ezetimibe and orlistat, alone or in combination, on high-density lipoprotein (HDL) subclasses and HDL-associated enzyme activities in overweight and obese patients with hyperlipidaemia (Journal article)

  Effects of ezetimibe, either alone or in combination with atorvastatin, on serum visfatin levels: a pilot study (Journal article)

  Effects of orlistat and fenofibrate combination on LDL phenotype in overweight and obese patients with metabolic syndrome. The fenorli study (Journal article)